Study finds shift toward immunotherapy in mucosal melanoma treatment
July 21, 2026
July 21, 2026
NEW YORK, July 21 -- The City University of New York Graduate School of Public Health and Health Policy posted the following news release:
* * *
Study finds shift toward immunotherapy in mucosal melanoma treatment
*
A study by Associate Professor Onur Baser and colleagues found that immunotherapy, especially PD-1/PD-L1-based regimens, has become the dominant treatment approach for older U.S. patients with mucosal melanoma, while surgery remains . . .
* * *
Study finds shift toward immunotherapy in mucosal melanoma treatment
*
A study by Associate Professor Onur Baser and colleagues found that immunotherapy, especially PD-1/PD-L1-based regimens, has become the dominant treatment approach for older U.S. patients with mucosal melanoma, while surgery remains . . .